Silicon Nitride Garners Interest from Dental Community at IAOCI Conference
In August 2021, Michael Marcroft, SINTX VP of Business Development, attended the International Academy of …
Read More
In August 2021, Michael Marcroft, SINTX VP of Business Development, attended the International Academy of …
Read More
SINTX Acquires
Learn more > HERE


This FDA 510(k) clearance for our portfolio of silicon nitride osteotomy wedges marks the official entry into the foot and ankle reconstruction market. These next-generation implants blend cutting-edge biomaterials science with surgical precision and are designed to elevate standards in orthopedic procedures. Learn more HERE.